At the end of the day, the right treatment depends on the person
There are no clinical studies and no evidence linking phytoestrogens to increased breast size
Furthermore, long-term, head-to-head comparisons against other weight loss methods are still limited, making definitive conclusions challenging
H., Cant, C., Wanders, R
Tesamorelin: Induces broad fat loss, particularly visceral fat, but via elevated HGH/IGF-1, which can bring both metabolic benefits and hormone-related risks Safety Profile AOD-9604: Well tolerated, with no significant effect on blood sugar or IGF-1 levels, making it appealing for long-term metabolic use
For individuals managing chronic conditions, the appeal of micro-dosing lies in its sustainability